Managed Care Cast

As health information technology (IT) tools are continually being introduced into the healthcare sphere, organizations are utilizing these tools to optimize care coordination, patient experience, and patient outcomes. Today, 2 organizations join us; 1 uses a 2-way text messaging platform to support patients and increase medication adherence, and the other is teaming up with a pharmaceutical company to develop health IT solutions in order to enhance precision medicine in oncology.

The introduction of biosimilars to the US market has led to an unprecedented amount of uncertainty as stakeholders try to understand the implications of their arrival. In the following Peer Exchange discussion from The Center for Biosimilars®, held in September 2017, industry experts discuss regulation, policy, and litigation issues in the world of biosimilars.

More and more, practices around the country are switching from paper-based systems to electronic health records (EHRs). EHRs are increasingly becoming a crucial tool in healthcare, improving communication and facilitating care coordination. However, with these benefits also come challenges and unintended consequences. Jacob Reider, MD, CEO of Alliance for Better Health, dicusses the benefits of EHRs, their consequences, and working toward a time when interoperability becomes a reality nationwide.

Healthcare could be improved if policy makers, leaders, and administrators thought more about the role of medical professionalism and the intrinsic motivations of physicians, said Richard J. Baron, MD, MACP, president and CEO of the American Board of Internal Medicine and the ABIM Foundation, during an interview with Patricia Salber, MD, MBA, of The Doctor Weigns In.

As the senior national correspondent at Kaiser Health News, Sarah Varney covers health policy, specifically looking at federal law and how it rolls out in states and local jurisdictions. During her conversation with Patricia Salber, MD, MBA, of The Doctor Weighs In, she explained how her articles are shaped by the time she spends in the field talking to people affected by the policy decisions made in Washington, DC, or state capitals.


Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo